129 related articles for article (PubMed ID: 908845)
41. Effects of topical corticosteroids on cell proliferation, cell cycle progression and apoptosis: in vitro comparison on HaCaT.
Guichard A; Humbert P; Tissot M; Muret P; Courderot-Masuyer C; Viennet C
Int J Pharm; 2015 Feb; 479(2):422-9. PubMed ID: 25556056
[TBL] [Abstract][Full Text] [Related]
42. Newer topical therapy in dermatology.
Bluefarb SM
Int J Dermatol; 1970; 9(3):200-8. PubMed ID: 5476381
[No Abstract] [Full Text] [Related]
43. [Comparative study of efficacy and effect on plasma cortisol levels of micronised desonide cream 0.1 p. 100 versus betamethasone dipropionate cream 0.05 p. 100 In the treatment of childhood atopic dermatitis].
Lebrun-Vignes B; Legrain V; Amoric J; Taïeb A
Ann Dermatol Venereol; 2000; 127(6-7):590-5. PubMed ID: 10930856
[TBL] [Abstract][Full Text] [Related]
44. Comparison of the cutaneous/systemic antiinflammatory activity ratios for desonide and hydrocortisone in various experimental models.
Tarayre JP; Aliaga M; Barbara M; Ballester R; Tisné-Versailles J; Couzinier JP
Arzneimittelforschung; 1988 Apr; 38(4):542-5. PubMed ID: 3401268
[TBL] [Abstract][Full Text] [Related]
45. Biological activity and characteristics of triamcinolone-acetonide formulated with the self-regulating drug carriers, Transfersomes.
Cevc G; Blume G
Biochim Biophys Acta; 2003 Aug; 1614(2):156-64. PubMed ID: 12896808
[TBL] [Abstract][Full Text] [Related]
46. Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy.
McMichael AJ; Griffiths CE; Talwar HS; Finkel LJ; Rafal ES; Hamilton TA; Voorhees JJ
Br J Dermatol; 1996 Jul; 135(1):60-4. PubMed ID: 8776360
[TBL] [Abstract][Full Text] [Related]
47. Electron-microscopic evaluation of collagen fibrils after topical corticosteroid therapy.
Groniowska M; Dabrowski J; Maciejewski W; Walski M
Dermatologica; 1976; 152 Suppl 1():147-53. PubMed ID: 133837
[TBL] [Abstract][Full Text] [Related]
48. Steroid atrophy--a histological appraisal.
Jones EW
Dermatologica; 1976; 152 Suppl 1():107-15. PubMed ID: 133833
[TBL] [Abstract][Full Text] [Related]
49. The characteristic feature of glucocorticoids after local application with reference to leucocyte migration and protein exudation.
Ishikawa H; Mori Y; Tsurufuji S
Eur J Pharmacol; 1969 Aug; 7(2):201-5. PubMed ID: 5345995
[No Abstract] [Full Text] [Related]
50. The effect of corticosteroids on human epidermal mitotic activity.
Fisher LB; Maibach HI
Arch Dermatol; 1971 Jan; 103(1):39-44. PubMed ID: 4321801
[No Abstract] [Full Text] [Related]
51. Anti-inflammatory adrenal steroids that neither inhibit skin collagen synthesis nor cause dermal atrophy.
DiPetrillo T; Lee H; Cutroneo KR
Arch Dermatol; 1984 Jul; 120(7):878-83. PubMed ID: 6547287
[TBL] [Abstract][Full Text] [Related]
52. Antiinflammatory activity and thymolytic effect of a new corticosteroid ester (I.S.F. 2073) by topical application.
Banfi S; Cornelli U; Carpi C
Curr Ther Res Clin Exp; 1976 Jan; 19(1):126-32. PubMed ID: 812657
[No Abstract] [Full Text] [Related]
53. Evaluation of the atrophogenic potential of different glucocorticoids using optical coherence tomography, 20-MHz ultrasound and profilometry; a double-blind, placebo-controlled trial.
Cossmann M; Welzel J
Br J Dermatol; 2006 Oct; 155(4):700-6. PubMed ID: 16965418
[TBL] [Abstract][Full Text] [Related]
54. A study of systemic and topical effects of topical steroid application through the comparison of two application schedules.
Fukaya Y; Masutani M; Koyama Y; Takahashi H; Ueda H
J Dermatol; 1990 Jan; 17(1):28-33. PubMed ID: 2329214
[TBL] [Abstract][Full Text] [Related]
55. Measurement of skin thickness: a comparison of two in vivo techniques with a conventional histometric method.
Dykes PJ; Marks R
J Invest Dermatol; 1977 Sep; 69(3):275-8. PubMed ID: 894062
[TBL] [Abstract][Full Text] [Related]
56. [Development and regression of dermal corticosteroid atrophy. 1. Change in the skinfold thickness].
Lubach D; Hinz E
Derm Beruf Umwelt; 1986; 34(5):146-9. PubMed ID: 2947794
[TBL] [Abstract][Full Text] [Related]
57. Paired comparison vasoconstrictor assays. A comparison of methods for the determination of relative vasoconstrictor potency of topically applied corticosteroids.
Poulsen BJ; Burdick K; Bessler S
Arch Dermatol; 1974 Mar; 109(3):367-71. PubMed ID: 4814938
[No Abstract] [Full Text] [Related]
58. Comparative toxicity study of hydrocortisone 17-butyrate 21-propionate (HBP) ointment and other topical corticosteroids in rats.
Kimura M; Tarumoto Y; Nakane S; Otomo S
Drugs Exp Clin Res; 1986; 12(8):643-52. PubMed ID: 3757761
[TBL] [Abstract][Full Text] [Related]
59. Hydrocortisone 17-butyrate (Locoid) 0.1% fatty cream versus desonide (Apolar) 0.1% ointment in the treatment of patients suffering from atopic dermatitis.
Rajka G; Verjans HL
J Int Med Res; 1986; 14(2):85-90. PubMed ID: 3516754
[TBL] [Abstract][Full Text] [Related]
60. Effects of topical ammonium lactate on cutaneous atrophy from a potent topical corticosteroid.
Lavker RM; Kaidbey K; Leyden JJ
J Am Acad Dermatol; 1992 Apr; 26(4):535-44. PubMed ID: 1597538
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
